These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 10547982

  • 1. [The characteristics of myocardial fatty acid metabolism in patients with left ventricular hypertrophy].
    Isobe N, Toyama T, Hoshizaki H, Oshima S, Taniguchi K, Iizuka T, Kanazawa N, Wakamatsu S, Arisaka H, Suzuki T, Nagai R, Inoue T, Endo K.
    Kaku Igaku; 1999 Sep; 36(7):725-33. PubMed ID: 10547982
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
    Miyanaga H, Kawasaki S, Yoneyama S, Hyougo T, Kamitani T, Takahashi T, Kunishige H.
    Kaku Igaku; 1997 Feb; 34(2):85-93. PubMed ID: 9095571
    [Abstract] [Full Text] [Related]

  • 3. [The characteristic feature of myocardial imaging with 123I-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid in hypertrophic cardiomyopathy with asymmetric septal hypertrophy].
    Ohtsuki K, Sugihara H, Ito K, Matsumoto K, Taniguchi Y, Terada K, Nakagawa T, Shima T, Kuribayashi T, Ochiai M.
    Kaku Igaku; 1995 Apr; 32(4):377-85. PubMed ID: 7776544
    [Abstract] [Full Text] [Related]

  • 4. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].
    Narita M, Kurihara T, Usami M, Honda M.
    Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646
    [Abstract] [Full Text] [Related]

  • 5. [Relationship between reduced myocardial uptake of beta-methyl-p-(123I)- iodophenyl-pentadecanoic acid (123I-BMIPP) and regional diastolic ventricular dysfunction in patients with hypertrophic cardiomyopathy].
    Morozumi T, Ishida Y, Hori M, Kamada T, Yamagami H, Kozuka T, Kusuoka H, Nishimura T.
    Kaku Igaku; 1993 Sep; 30(9):1037-47. PubMed ID: 8230824
    [Abstract] [Full Text] [Related]

  • 6. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
    Kobayashi H, Nakata T, Han S, Takahashi N, Hashimoto A, Tsuchihashi K, Nagao K, Tanaka S, Shimamoto K, Iimura O.
    J Cardiol; 1994 Sep; 24(1):35-43. PubMed ID: 8158529
    [Abstract] [Full Text] [Related]

  • 7. [Phase 2 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating myocardial fatty acid metabolism].
    Torizuka K, Yonekura Y, Nishimura T, Tamaki N, Uehara T.
    Kaku Igaku; 1992 Mar; 29(3):305-17. PubMed ID: 1583804
    [Abstract] [Full Text] [Related]

  • 8. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy].
    Ohtsuki K, Sugihara H, Umamoto I, Harada Y, Shiga K, Nakamura T, Nakagawa T, Azuma A, Kohno Y, Katsume H.
    Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884
    [Abstract] [Full Text] [Related]

  • 9. [Relationship between ventricular arrhythmias and myocardial fatty acid metabolism in patients with coronary heart disease: evaluation using iodine-123 beta-methyl-p-iodophenyl-pentadecanoic acid].
    Mori H, Sakamoto T, Ueda Y, Yano K.
    J Cardiol; 1999 Aug; 34(2):61-9. PubMed ID: 10466087
    [Abstract] [Full Text] [Related]

  • 10. Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy.
    Ohtsuki K, Sugihara H, Kuribayashi T, Nakagawa M.
    J Nucl Med; 1999 Dec; 40(12):2007-13. PubMed ID: 10616878
    [Abstract] [Full Text] [Related]

  • 11. Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.
    Nishimura T, Nagata S, Uehara T, Morozumi T, Ishida Y, Nakata T, Iimura O, Kurata C, Wakabayashi Y, Sugihara H, Otsuki K, Wada T, Koga Y.
    Ann Nucl Med; 1996 Feb; 10(1):71-8. PubMed ID: 8814730
    [Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (123I-BMIPP).
    Ohtsuki K, Sugihara H, Umamoto I, Nakamura T, Nakagawa T, Nakagawa M.
    Nucl Med Commun; 1994 Jun; 15(6):441-7. PubMed ID: 8078640
    [Abstract] [Full Text] [Related]

  • 13. [Assessment of 123I-beta-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial scintigraphy in patients of chronic right ventricular overload--fatty acid metabolism in right ventricular myocardium].
    Mutoh H.
    Kaku Igaku; 1997 Oct; 34(10):917-24. PubMed ID: 9404099
    [Abstract] [Full Text] [Related]

  • 14. Myocardial metabolism of 123I-BMIPP in patients with hypertrophic cardiomyopathy: assessment by radial long-axis SPET.
    Chen SL, Uehara T, Morozumi T, Yamagami H, Kusuoka H, Nishimura T.
    Nucl Med Commun; 1995 May; 16(5):336-43. PubMed ID: 7659385
    [Abstract] [Full Text] [Related]

  • 15. Detection of impaired fatty acid metabolism in right ventricular hypertrophy: assessment by I-123 beta-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial single-photon emission computed tomography.
    Kim Y, Goto H, Kobayashi K, Sawada Y, Miyake Y, Fujiwara G, Chiba H, Okada T, Nishimura T.
    Ann Nucl Med; 1997 Aug; 11(3):207-12. PubMed ID: 9310169
    [Abstract] [Full Text] [Related]

  • 16. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy.
    Kurata C, Tawarahara K, Taguchi T, Aoshima S, Kobayashi A, Yamazaki N, Kawai H, Kaneko M.
    J Nucl Med; 1992 Jan; 33(1):6-13. PubMed ID: 1530969
    [Abstract] [Full Text] [Related]

  • 17. Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cardiomyopathies: by 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C, Shuke N, Okizaki A, Yamamoto W, Sato J, Ishikawa Y, Ohta T, Hasebe N, Kikuchi K, Aburano T.
    Ann Nucl Med; 2003 Oct; 17(7):541-8. PubMed ID: 14651352
    [Abstract] [Full Text] [Related]

  • 18. Creatine depletion and altered fatty acid metabolism in diseased human hearts: clinical investigation using 1H magnetic resonance spectroscopy and 123I BMIPP myocardial scintigraphy.
    Nakae I, Mitsunami K, Matsuo S, Horie M.
    Acta Radiol; 2007 May; 48(4):436-43. PubMed ID: 17453526
    [Abstract] [Full Text] [Related]

  • 19. Discrepancies between myocardial perfusion and free fatty acid metabolism in patients with hypertrophic cardiomyopathy.
    Shimonagata T, Nishimura T, Uehara T, Hayashida K, Kumita S, Ohno A, Nagata S, Miyatake K.
    Nucl Med Commun; 1993 Nov; 14(11):1005-13. PubMed ID: 8290156
    [Abstract] [Full Text] [Related]

  • 20. [Simultaneous evaluation of myocardial perfusion and fatty acid metabolism using dynamic SPECT with single injection of 123I-15-(p-iodophenyl)-3-methyl pentadecanoic acid (BMIPP)].
    Kobayashi H, Asano R, Oka T, Inoue S, Momose M, Ikkatai Y, Sumiyoshi T, Matsumoto N, Horie T, Kusakabe K.
    Kaku Igaku; 1995 Jan; 32(1):19-29. PubMed ID: 7897865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.